Trial record 1 of 21 for:    stargardt's macular dystrophy
Previous Study | Return to List | Next Study

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Ocata Therapeutics Identifier:
First received: April 28, 2011
Last updated: October 21, 2015
Last verified: October 2015